And studies have shown that SHOX2/RASSF1A methylation exhibits higher sensitivity to small cell lung cancer (SCLC) and squamous cell carcinoma (SCC) than adenocarcinoma.[26]. Here, SHOX2 is linked to squamous cell carcinoma.